Reading Reports of Clinical Trial Results
John M. Kane, MD
J Clin Psychiatry 2005;66(5):653-653
© Copyright 2017 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
-
-
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
-
Subscribe
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
-
-
Activate
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
-
Sign in
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
-
Click here to login.
-
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
The ASCP is particularly concerned
about enhancing the knowledge base and the
success of knowledge transfer in clinical
psychopharmacology. Given the number of
clinical trials being published and the
amount of trial data available to clinicians,
we discuss some key elements of trial design,
analysis, and reporting.
The goal of clinical trials in psychopharmacology
is to characterize the efficacy
and safety properties of the treatment being
studied.